Bcl-xL, overexpressed in human lung adenocarcinoma (ACL), is an ideal target for antisense therapy

被引:0
|
作者
Li, E
Xiao, H
Vikram, B
机构
[1] NYU Med Ctr, New York, NY 10016 USA
[2] Montefiore Med Ctr, Bronx, NY 10467 USA
关键词
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
1313
引用
收藏
页码:223A / 223A
页数:1
相关论文
共 50 条
  • [1] Bcl-xL, overexpressed in human lung adenocarcinoma (ACL), is an ideal target for antisense therapy
    Li, E
    Xiao, H
    Vikram, B
    LABORATORY INVESTIGATION, 2001, 81 (01) : 223A - 223A
  • [2] Differential expression of Bcl-2 and Bcl-xL in human small cell lung cancer (SCLC) and adenocarcinoma of the lung (ACL)
    Li, E
    Xiao, H
    Vikram, B
    LABORATORY INVESTIGATION, 2001, 81 (01) : 223A - 223A
  • [3] Differential expression of Bcl-2 and Bcl-xL in human small cell lung cancer (SCLC) and adenocarcinoma of the lung (ACL)
    Li, E
    Xiao, H
    Vikram, B
    MODERN PATHOLOGY, 2001, 14 (01) : 223A - 223A
  • [4] Sequence of Bcl-XL antisense oligonucleotides
    Tari, AM
    BLOOD, 1999, 94 (03) : 1142 - 1143
  • [5] Bcl-xL is a chemoresistance factor in human melanoma cells that can be inhibited by antisense therapy
    Heere-Ress, E
    Thallinger, C
    Lucas, T
    Schlagbauer-Wadl, H
    Wacheck, V
    Monia, BP
    Wolff, K
    Pehamberger, H
    Jansen, B
    INTERNATIONAL JOURNAL OF CANCER, 2002, 99 (01) : 29 - 34
  • [6] Bcl-xL antisense oligonucleotides chemosensitize human glioblastoma cells
    Guensberg, P
    Wacheck, V
    Lucas, T
    Monia, B
    Pehamberger, H
    Eichler, HG
    Jansen, B
    CHEMOTHERAPY, 2002, 48 (04) : 189 - 195
  • [7] Bcl-XL but Not Bcl-2 Is a Potential Target in Medulloblastoma Therapy
    Westhoff, Mike-Andrew
    Schuler-Ortoli, Marie
    Zerrinius, Daniela
    Hadzalic, Amina
    Schuster, Andrea
    Strobel, Hannah
    Scheuerle, Angelika
    Wong, Tiana
    Wirtz, Christian Rainer
    Debatin, Klaus-Michael
    Peraud, Aurelia
    PHARMACEUTICALS, 2022, 15 (01)
  • [8] Sequence of Bcl-XL antisense oligonucleotides -: Response
    Dibbert, B
    Simon, HU
    BLOOD, 1999, 94 (03) : 1143 - 1143
  • [9] Antisense therapy for malignant mesothelioma with oligonucleotides targeting the bcl-xl gene product
    Smythe, WR
    Mohuiddin, I
    Ozveran, M
    Cao, XBX
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2002, 123 (06): : 1191 - 1198
  • [10] Bcl-XL small interfering RNA sensitizes cisplatin-resistant human lung adenocarcinoma cells
    Lei, Xiaoyong
    Huang, Zexiang
    Zhong, Miao
    Zhu, Bingyang
    Tang, Shengsong
    Liao, Duanfang
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2007, 39 (05) : 344 - 350